PE20090944A1 - PIRIMIDINAS BICICLICAS FUSIONADAS COMO INHIBIDORES DE LA VIA Pi3K/AKT - Google Patents

PIRIMIDINAS BICICLICAS FUSIONADAS COMO INHIBIDORES DE LA VIA Pi3K/AKT

Info

Publication number
PE20090944A1
PE20090944A1 PE2008001378A PE2008001378A PE20090944A1 PE 20090944 A1 PE20090944 A1 PE 20090944A1 PE 2008001378 A PE2008001378 A PE 2008001378A PE 2008001378 A PE2008001378 A PE 2008001378A PE 20090944 A1 PE20090944 A1 PE 20090944A1
Authority
PE
Peru
Prior art keywords
phenyl
pyrimidine
methyl
pi3k
triazol
Prior art date
Application number
PE2008001378A
Other languages
English (en)
Inventor
Swen Ulfried Karl Raimund Holder
Matthias Vennemann
Gerrit Beneke
Armin Zulch
Volker Gekeler
Thomas Beckers
Astrid Zimmermann
Hemant Joshi
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07118736A external-priority patent/EP2050748A1/en
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of PE20090944A1 publication Critical patent/PE20090944A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

REFERIDA A UN DERIVADO DE PIRIMIDINA DE FORMULA (I), DONDE EL ANILLO B Y LA PIRIMIDINA A LA CUAL ESTA FUSIONADO FORMAN UN SISTEMA DE ANILLOS SELECCIONADOS DE (a), (b) Y (c); R1 ES H, ALQUILO C1-C4, HALOGENO, AMINO, ENTRE OTROS; R3 ES H O ALQUILO C1-C4; R4 ES FENILO O TIENILO; R5 ES H, ALCOXI C1-C4, AMINO, CICLOALQUILO C3-C7, ENTRE OTROS; R6 ES H O ALQUILO C1-C4; R7 ES -W-Y; W ES HETEROARILENO MONOCICLICO DE 5 MIEMBROS QUE COMPRENDE UN ATOMO DE NITROGENO Y OPCIONALMENTE HETEROATOMOS ADICIONALES SELECCIONADOS DE O, N Y S; Y ES FENILO O HETEROARILO MONOCICLICO DE 5 O 6 MIEMBROS QUE COMPRENDE UN ATOMO DE NITROGENO Y OPCIONALMENTE HETEROATOMOS ADICIONALES SELECCIONADOS DE O, N Y S. SON COMPUESTOS PREFERIDOS: 6-FENIL-7-(4-{[4-(3-PIRIDIN-2-IL-1,2,4-TRIAZOL-5-IL)PIPERIDIN-1-IL]METIL}FENIL)IMIDAZO[1,2a]-PIRIMIDINA, 6-FENIL-5-(4-{[4-(5-PIRIDIN-2-IL-1,2,4-TRIAZOL-3-IL)PIPERIDIN-1-IL]METILçFENIL)[1,2,4]TRIAZOLO[1,5a]-PIRIMIDINA, 2-METIL-6-FENIL-5-(4-{[4-(5-PIRIDIN-2-IL-1,2,4-TRIAZOL-3-IL)PIPERIDIN-1-IL]METIL}FENIL)[1,2,4]-TRIAZOLO[1,5-a]PIRIMIDINA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHICIDORES DE LA VIA Pi3K/Akt Y SON UTILES EN EL TRATAMIENTO DE ENFERMEDADES PROLIFERATIVAS
PE2008001378A 2007-08-14 2008-08-14 PIRIMIDINAS BICICLICAS FUSIONADAS COMO INHIBIDORES DE LA VIA Pi3K/AKT PE20090944A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1572MU2007 2007-08-14
EP07118736A EP2050748A1 (en) 2007-10-18 2007-10-18 Novel fused pyrimidines

Publications (1)

Publication Number Publication Date
PE20090944A1 true PE20090944A1 (es) 2009-08-09

Family

ID=40153211

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001378A PE20090944A1 (es) 2007-08-14 2008-08-14 PIRIMIDINAS BICICLICAS FUSIONADAS COMO INHIBIDORES DE LA VIA Pi3K/AKT

Country Status (37)

Country Link
US (2) US7776864B2 (es)
EP (1) EP2188291B1 (es)
JP (1) JP5344637B2 (es)
KR (1) KR20100053556A (es)
CN (1) CN101778851B (es)
AR (1) AR067945A1 (es)
AU (1) AU2008288392B2 (es)
BR (1) BRPI0815207A2 (es)
CA (1) CA2694058C (es)
CL (1) CL2008002398A1 (es)
CO (1) CO6260077A2 (es)
CR (1) CR11270A (es)
CY (1) CY1113486T1 (es)
DK (1) DK2188291T3 (es)
DO (1) DOP2010000058A (es)
EA (1) EA020996B1 (es)
EC (1) ECSP109964A (es)
ES (1) ES2396177T3 (es)
HN (1) HN2010000313A (es)
HR (1) HRP20121022T1 (es)
IL (1) IL203163A (es)
MA (1) MA31608B1 (es)
MX (1) MX2010001746A (es)
MY (1) MY169738A (es)
NZ (1) NZ583267A (es)
PA (1) PA8793201A1 (es)
PE (1) PE20090944A1 (es)
PL (1) PL2188291T3 (es)
PT (1) PT2188291E (es)
RS (1) RS52559B (es)
SI (1) SI2188291T1 (es)
SV (1) SV2010003483A (es)
TN (1) TN2010000070A1 (es)
TW (1) TWI439272B (es)
UA (1) UA99735C2 (es)
UY (1) UY31293A1 (es)
WO (1) WO2009021992A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA97257C2 (en) * 2006-10-19 2012-01-25 Такеда Фармасьютикал Компани Лимитед Indole derivatives
UY31293A1 (es) 2007-08-14 2009-03-31 Pirimidinas biciclicas fusionadas
JP5599783B2 (ja) 2008-05-30 2014-10-01 アムジエン・インコーポレーテツド Pi3キナーゼの阻害薬
KR20110114663A (ko) * 2009-02-13 2011-10-19 바이엘 파마 악티엔게젤샤프트 융합된 피리미딘
EP2396331B1 (en) * 2009-02-13 2013-10-16 Bayer Intellectual Property GmbH Fused pyrimidines as akt inhibitors
WO2010114780A1 (en) 2009-04-01 2010-10-07 Merck Sharp & Dohme Corp. Inhibitors of akt activity
WO2010125799A1 (ja) 2009-04-27 2010-11-04 塩野義製薬株式会社 Pi3k阻害活性を有するウレア誘導体
US20130184273A1 (en) * 2010-07-13 2013-07-18 Bayer Intellectual Property Gmbh Bicyclic pyrimidines
ES2539257T3 (es) 2010-07-28 2015-06-29 Bayer Intellectual Property Gmbh Imidazo[1,2-b]piridazinas sustituidas
EA024890B1 (ru) 2011-04-07 2016-10-31 Байер Интеллектчуал Проперти Гмбх Имидазопиридазины в качестве ингибиторов akt киназы
RU2644769C2 (ru) 2013-01-23 2018-02-14 Астразенека Аб Химические соединения
US20140274685A1 (en) 2013-03-15 2014-09-18 Bayer Cropscience Lp Compositions, additives, and methods for mitigating or controlling seed dust
UA121297C2 (uk) * 2013-03-15 2020-05-12 Байєр Кропсайєнс Лп Композиції, добавки та способи зменшення або контролювання пилу насіння
WO2019055750A1 (en) 2017-09-15 2019-03-21 Aduro Biotech, Inc. PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004502691A (ja) 2000-06-30 2004-01-29 ワイス 抗癌薬としての置換トリアゾロピリミジン
US7449488B2 (en) * 2002-06-04 2008-11-11 Schering Corporation Pyrazolopyrimidines as protein kinase inhibitors
WO2004096131A2 (en) 2003-04-24 2004-11-11 Merck & Co., Inc. Inhibitors of akt activity
EP1737843B1 (en) * 2004-04-09 2011-02-23 Merck Sharp & Dohme Corp. Inhibitors of akt activity
TW200618800A (en) * 2004-08-03 2006-06-16 Uriach Y Compania S A J Heterocyclic compounds
AU2005290081B2 (en) * 2004-08-23 2010-12-02 Merck Sharp & Dohme Corp. Inhibitors of Akt activity
WO2006065601A2 (en) 2004-12-15 2006-06-22 Merck & Co., Inc. Inhibitors of akt activity
US7994172B2 (en) * 2004-12-28 2011-08-09 Exelixis, Inc. [1H-pyrazolo[3, 4-D]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (P70s6k, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases
AU2006216998B2 (en) 2005-02-14 2010-12-23 Merck Sharp & Dohme Corp. Inhibitors of Akt activity
AU2006258124B8 (en) 2005-06-10 2010-01-07 Merck Sharp & Dohme Corp. Inhibitors of Akt activity
UY31293A1 (es) 2007-08-14 2009-03-31 Pirimidinas biciclicas fusionadas
KR20110114663A (ko) * 2009-02-13 2011-10-19 바이엘 파마 악티엔게젤샤프트 융합된 피리미딘

Also Published As

Publication number Publication date
NZ583267A (en) 2012-03-30
AU2008288392A1 (en) 2009-02-19
EP2188291A2 (en) 2010-05-26
AR067945A1 (es) 2009-10-28
US20090137607A1 (en) 2009-05-28
AU2008288392B2 (en) 2013-10-24
BRPI0815207A2 (pt) 2017-03-28
SI2188291T1 (sl) 2013-01-31
PA8793201A1 (es) 2009-04-23
MY169738A (en) 2019-05-14
MA31608B1 (fr) 2010-08-02
EP2188291B1 (en) 2012-09-19
CN101778851A (zh) 2010-07-14
UY31293A1 (es) 2009-03-31
JP5344637B2 (ja) 2013-11-20
EA020996B1 (ru) 2015-03-31
EA201000298A1 (ru) 2010-10-29
IL203163A (en) 2015-01-29
MX2010001746A (es) 2010-03-10
RS52559B (sr) 2013-04-30
HN2010000313A (es) 2013-03-18
CR11270A (es) 2010-05-19
ES2396177T3 (es) 2013-02-19
WO2009021992A3 (en) 2009-04-16
WO2009021992A2 (en) 2009-02-19
TW200922592A (en) 2009-06-01
CY1113486T1 (el) 2016-06-22
CN101778851B (zh) 2013-05-08
HK1146273A1 (en) 2011-05-20
CA2694058C (en) 2016-06-07
US7776864B2 (en) 2010-08-17
HRP20121022T1 (hr) 2013-01-31
US8614218B2 (en) 2013-12-24
US20100184782A1 (en) 2010-07-22
PL2188291T3 (pl) 2013-06-28
SV2010003483A (es) 2010-07-06
TN2010000070A1 (en) 2011-09-26
KR20100053556A (ko) 2010-05-20
CL2008002398A1 (es) 2009-07-31
CA2694058A1 (en) 2009-02-19
PT2188291E (pt) 2012-12-20
ECSP109964A (es) 2010-03-31
UA99735C2 (uk) 2012-09-25
DOP2010000058A (es) 2010-02-28
TWI439272B (zh) 2014-06-01
DK2188291T3 (da) 2013-01-07
JP2010535848A (ja) 2010-11-25
CO6260077A2 (es) 2011-03-22

Similar Documents

Publication Publication Date Title
PE20120534A1 (es) PIRIMIDINAS FUSIONADAS COMO INHIBIDORES DE Akt
PE20090596A1 (es) Imidazoles biciclicos fusionados
PE20091833A1 (es) Derivados heterociclicos espiro biciclicos o heterociclicos biciclicos, puenteados, de pirazolo [1,5-a]pirimidinas como inhibidores de quinasas raf y metodos para su preparacion
PE20140390A1 (es) Derivados de imidazo[1,2-b]piridazina e imidazo[4,5-b]piridina como inhibidores de jak
PE20080315A1 (es) DERIVADOS DE PIRAZOLO-[3,4-d]-PIRIMIDINAS COMO INHIBIDORES DE CINASA PI-3
PE20090370A1 (es) Derivados de heterociclo fusionado como inhibidores de quinasa
PE20151249A1 (es) Derivados de pirazolopirimidina como inhibidores de jak quinasas
PE20110560A1 (es) NUEVOS DERIVADOS DE TRIAZOLO[4,3-a]PIRIDINA, SU PROCEDIMIENTO DE PREPARACION, SU APLICACION COMO MEDICAMENTOS, COMPOSICIONES FARMACEUTICAS Y NUEVA UTILIZACION PARTICULARMENTE COMO INHIBIDORES DE MET
PE20141557A1 (es) Derivado de pirazoloquinolina
PE20170189A1 (es) Nuevos derivados de pirazolo pirimidina y su uso como inhibidores de malt1
PE20110545A1 (es) Compuestos de triazolopiridina como inhibidores de jak
PE20091211A1 (es) Derivados de pirazolopirimidina como moduladores de pde9a
PE20110411A1 (es) Imidazopiridazinacarbonitrilos como inhibidores de quinasa
PE20110995A1 (es) DERIVADOS DE PIRROLO[3,4-e]PIRIMIDINA COMO INHIBIDORES DE PDE1
HRP20191268T1 (hr) Derivati tieno[2,3-c]pirol-4-ona kao inhibitori erk
PE20080548A1 (es) Derivados de [4,5']bipirimidinil-6,4'-diamina como inhibidores de cinasa de proteina
EA201170771A1 (ru) Органические соединения
PE20090492A1 (es) Compuestos heterociclos como inhibidores de cinasa de fosfatidil-inositol-3
PE20120107A1 (es) Inhibidores de proteina cinasa
PE20081612A1 (es) Analogos de las pterinas
PE20091116A1 (es) Derivados de piridina y pirazina como inhibidores de tirosina quinasas
PE20110944A1 (es) DERIVADOS DE PIRAZOLO[3,4-d]PIRIMIDINA COMO INHIBIDORES PDE1
PE20170666A1 (es) 2-(morfolin-4-il)-1,7-naftiridinas
PE20091083A1 (es) Moduladores tieno- y furo- pirimidina del receptor de histamina h4
MX2009010728A (es) Compuestos de imidazo[1,2-a]piridina como inhibidores de la tirosina-cinasa repectora.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed